Company's Grants Support Search For Alternatives To Animal Testing

The U.S. Department of Agriculture estimates that each year as many as 20 million animals are used in various university and industry settings for basic research and product testing. This figure represents a sizable drop from the late 1970s, when the USDA estimated that about 33 million animals per year were used. Two reasons are usually cited for this trend, says Daniel Ringler, director of the Unit for Laboratory Animal Medicine at the University of Michigan. First, many researchers have al

Written byLee Katterman
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

First, many researchers have altered or discontinued some animal studies because of the rising cost of using animals under increasingly stringent federal regulations. These extensive new rules have resulted from Congress' response to the demands of animal rights groups and public concern over the alleged mistreatment of animal subjects.

A second reason, says Ringler, is the development of alternative testing methods that require fewer animals or eliminate the use of animal subjects altogether (The Scientist, July 22, 1991, page 23). "Progress toward the use of nonanimal tests, however, has been very slow," he says. Assessing the validity of nonanimal methods as compared with that of long-used animal tests is difficult. In addition, several in vitro tests may be required to replace a single animal model, so switching to nonanimal methods may take more time, money, and effort than deemed practical by labs.

One large corporation interested in animal alternatives is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies